R44CA199767/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2020	1
2022	1
2023	1
2025	0

Page 1

SLAMF7 as a Promising Immunotherapeutic Target in Multiple Myeloma Treatments.

Chu E, Wu J, Kang SS, Kang Y. Chu E, et al. Curr Oncol. 2023 Aug 27;30(9):7891-7903. doi: 10.3390/curroncol30090573. Curr Oncol. 2023. PMID: 37754488 Free PMC article. Review.

Mechanistic Studies and a Retrospective Cohort Study: The Interaction between PPAR Agonists and Immunomodulatory Agents in Multiple Myeloma.

Wu J, Chu E, Paul B, Kang Y. Wu J, et al. Cancers (Basel). 2022 Oct 27;14(21):5272. doi: 10.3390/cancers14215272. Cancers (Basel). 2022. PMID: 36358696 Free PMC article.

The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors.

Paul B, Zhao Y, Loitsch G, Feinberg D, Mathews P, Barak I, Dupuis M, Li Z, Rein L, Wang E, Kang Y. Paul B, et al. Cancer Med. 2020 Aug;9(16):5869-5880. doi: 10.1002/cam4.3265. Epub 2020 Jul 6. Cancer Med. 2020. PMID: 32628819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year